Screener
Generate Biomedicines, Inc. GENB Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Generate Biomedicines, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Generate Biomedicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336437
FAQ
- What is Generate Biomedicines, Inc.'s current ratio?
- Generate Biomedicines, Inc. (GENB) reported current ratio of 8.3× in Q2 2026.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Generate Biomedicines, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude